Insider activities archive   |   Recent insider buys   |   Top 10 insider buys   |   Search Insiders!



Insider Trading: AMYLIN PHARMACEUTICALS INC , Part 2

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of AMYLIN PHARMACEUTICALS INC in the last 24 months are illustrated in figures 1 and 2. Table 1 shows the monthly insider trading data of AMYLIN PHARMACEUTICALS INC since year 2005. (See page 1 of this report.) Table 2 shows the detailed insider transactions of AMYLIN PHARMACEUTICALS INC since 2005. The reporting company's ticker symbol is AMLN. The reporting company's CIK number is 881464.

The total value of stock buying since 2005 is $166,931,749. The total value of stock sales is $72,155,307. The total value of stock exercises is $8,052,588.


1 year stock price chart,   1 day stock price chart
opopp
opopopop

Figure 1. Monthly insider transaction values at AMYLIN PHARMACEUTICALS INC (AMLN) in the past 24 months. The trade values of insider stock buys, sales, and option exercises are in logarithmic scale as shown on the right axis labels. The detailed monthly and daily insider transactions are listed in the 2 tables below.

  • 08

  • 09

  • 10

  • 11

  • 12

  • 01 2007

  • 02

  • 03

  • 04

  • 05

  • 06

  • 07

  • 08

  • 09

  • 10

  • 11

  • 12

  • 01 2008

  • 02

  • 03

  • 04

  • 05

  • 06

  • 07

  • $131,997k

    $13,199k

    $1,319k

    $131k

  • Buy
  • Sale
  • Option Exercise

Figure 2. Average prices of insider buys, sales, and option exercises at AMYLIN PHARMACEUTICALS INC (AMLN) in the past 24 months. See table 2 for insider transaction details.

  • 08

  • 09

  • 10

  • 11

  • 12

  • 01 2007

  • 02

  • 03

  • 04

  • 05

  • 06

  • 07

  • 08

  • 09

  • 10

  • 11

  • 12

  • 01 2008

  • 02

  • 03

  • 04

  • 05

  • 06

  • 07

  • $48.99

    $36.74

    $24.49

    $12.25




Table 2. Detailed insider stock purchases, sales, and option exercises for AMYLIN PHARMACEUTICALS INC (AMLN) , Part 2
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2007-08-06 Graham Ginger L (Executive Advisor) Sale 10,000 49.50 495,013
2007-08-06 Graham Ginger L (Executive Advisor) Option Exercise 10,000 4.38 43,750
2007-08-06 Greene Howard E Jr (Director) Sale 3,846 48.67 187,189
2007-08-02 Cook Joseph C Jr (Director) Sale 100 46.63 4,663
2007-08-01 Gergen Mark J (Sr VP, Corporate Development) Sale 500 46.50 23,250
2007-08-01 Gergen Mark J (Sr VP, Corporate Development) Option Exercise 500 16.80 8,400
2007-08-01 Rowland Lloyd A (VP, Gov/Compliance, Secretary) Sale 2,000 46.31 92,622
2007-08-01 Rowland Lloyd A (VP, Gov/Compliance, Secretary) Option Exercise 2,000 18.85 37,700
2007-08-01 Kolterman Orville G (Sr VP Clinical and Regulatory) Sale 1,700 46.50 79,050
2007-08-01 Kolterman Orville G (Sr VP Clinical and Regulatory) Option Exercise 1,700 9.62 16,362
2007-08-01 Eberhard Craig A (VP Sales) Sale 2,000 46.31 92,622
2007-08-01 Eberhard Craig A (VP Sales) Option Exercise 2,000 18.85 37,700
2007-08-01 Baron Alain D (Sr VP Research) Sale 3,000 46.50 139,500
2007-08-01 Baron Alain D (Sr VP Research) Option Exercise 3,000 7.19 21,562
2007-08-01 Cook Joseph C Jr (Director) Sale 9,900 46.54 460,731
2007-07-31 Foletta Mark G (Senior VP, Finance & CFO) Sale 3,500 47.43 166,022
2007-07-31 Foletta Mark G (Senior VP, Finance & CFO) Option Exercise 3,500 13.25 46,375
2007-07-27 Cook Joseph C Jr (Director) Option Exercise 140,000 2.66 371,840
2007-07-24 Gergen Mark J (Sr VP, Corporate Development) Sale 500 45.00 22,500
2007-07-24 Gergen Mark J (Sr VP, Corporate Development) Option Exercise 500 16.80 8,400
2007-07-24 Baron Alain D (Sr VP Research) Sale 2,000 45.50 91,000
2007-07-24 Baron Alain D (Sr VP Research) Option Exercise 2,000 9.57 19,137
2007-07-23 Greene Howard E Jr (Director) Sale 3,846 43.34 166,699
2007-07-18 Baron Alain D (Sr VP Research) Sale 1,000 43.18 43,180
2007-07-18 Baron Alain D (Sr VP Research) Option Exercise 1,000 11.95 11,950
2007-07-17 Cook Joseph C Jr (Director) Sale 10,000 42.96 429,616
2007-07-16 Kolterman Orville G (Sr VP Clinical and Regulatory) Sale 6,700 43.69 292,705
2007-07-16 Kolterman Orville G (Sr VP Clinical and Regulatory) Option Exercise 6,700 8.42 56,391
2007-07-12 Baron Alain D (Sr VP Research) Sale 2,000 43.00 86,000
2007-07-12 Baron Alain D (Sr VP Research) Option Exercise 2,000 7.19 14,375
2007-07-09 Greene Howard E Jr (Director) Sale 3,846 42.33 162,804
2007-07-03 Cook Joseph C Jr (Director) Sale 10,000 41.92 419,189
2007-07-02 Gergen Mark J (Sr VP, Corporate Development) Sale 500 41.20 20,600
2007-07-02 Gergen Mark J (Sr VP, Corporate Development) Option Exercise 500 16.80 8,400
2007-07-02 Rowland Lloyd A (VP, Gov/Compliance, Secretary) Sale 2,000 41.00 82,000
2007-07-02 Rowland Lloyd A (VP, Gov/Compliance, Secretary) Option Exercise 2,000 18.85 37,700
2007-07-02 Kolterman Orville G (Sr VP Clinical and Regulatory) Sale 5,000 41.16 205,809
2007-07-02 Kolterman Orville G (Sr VP Clinical and Regulatory) Option Exercise 5,000 1.61 8,047
2007-06-29 Foletta Mark G (Senior VP, Finance & CFO) Sale 2,500 41.38 103,455
2007-06-29 Foletta Mark G (Senior VP, Finance & CFO) Option Exercise 2,500 13.25 33,125
2007-06-25 Greene Howard E Jr (Director) Sale 3,846 41.34 158,991
2007-06-18 Baron Alain D (Sr VP Research) Sale 1,000 42.97 42,970
2007-06-18 Baron Alain D (Sr VP Research) Option Exercise 1,000 9.62 9,625
2007-06-15 Kolterman Orville G (Sr VP Clinical and Regulatory) Sale 6,700 42.99 288,031
2007-06-15 Kolterman Orville G (Sr VP Clinical and Regulatory) Option Exercise 6,700 7.81 52,343
2007-06-12 Graham Ginger L (Executive Advisor) Option Exercise 2,898 23.00 66,654
2007-06-11 Greene Howard E Jr (Director) Sale 3,846 41.46 159,472
2007-06-04 Cook Joseph C Jr (Director) Sale 10,000 44.77 447,656
2007-06-01 Gergen Mark J (Sr VP, Corporate Development) Sale 1,000 46.16 46,160
2007-06-01 Gergen Mark J (Sr VP, Corporate Development) Option Exercise 1,000 16.80 16,800
2007-06-01 Rowland Lloyd A (VP, Gov/Compliance, Secretary) Sale 2,000 46.64 93,280
2007-06-01 Rowland Lloyd A (VP, Gov/Compliance, Secretary) Option Exercise 2,000 18.85 37,700
2007-06-01 Kolterman Orville G (Sr VP Clinical and Regulatory) Sale 5,000 46.12 230,615
2007-06-01 Kolterman Orville G (Sr VP Clinical and Regulatory) Option Exercise 5,000 .31 1,565
2007-06-01 Eberhard Craig A (VP Sales) Sale 2,000 46.00 91,999
2007-06-01 Eberhard Craig A (VP Sales) Option Exercise 2,000 18.85 37,700
2007-06-01 Baron Alain D (Sr VP Research) Sale 4,000 46.16 184,640
2007-06-01 Baron Alain D (Sr VP Research) Option Exercise 4,000 9.06 36,255
2007-06-01 Testman Thomas R (Director) Sale 12,000 46.62 559,382
2007-06-01 Testman Thomas R (Director) Option Exercise 12,000 16.23 194,760
2007-05-31 Foletta Mark G (Senior VP, Finance & CFO) Sale 6,500 45.79 297,662
2007-05-31 Foletta Mark G (Senior VP, Finance & CFO) Option Exercise 6,500 13.25 86,125
2007-05-31 Wilson James N (Director) Sale 2,166 46.24 100,155
2007-05-30 Baron Alain D (Sr VP Research) Sale 1,000 46.00 46,000
2007-05-30 Baron Alain D (Sr VP Research) Option Exercise 1,000 11.95 11,950
2007-05-29 Greene Howard E Jr (Director) Sale 3,846 45.20 173,831
2007-05-25 Testman Thomas R (Director) Sale 20,000 44.88 897,606
2007-05-25 Testman Thomas R (Director) Option Exercise 20,000 16.99 339,799
2007-05-22 Wilson James N (Director) Sale 500 45.52 22,760
2007-05-21 Gergen Mark J (Sr VP, Corporate Development) Sale 500 45.00 22,500
2007-05-21 Gergen Mark J (Sr VP, Corporate Development) Option Exercise 500 16.80 8,400
2007-05-21 Baron Alain D (Sr VP Research) Sale 1,000 45.00 45,000
2007-05-21 Baron Alain D (Sr VP Research) Option Exercise 1,000 10.94 10,940
2007-05-21 Wilson James N (Director) Sale 2,166 44.80 97,036
2007-05-17 Cook Joseph C Jr (Director) Sale 10,000 42.52 425,177
2007-05-16 Baron Alain D (Sr VP Research) Sale 1,000 42.29 42,290
2007-05-16 Baron Alain D (Sr VP Research) Option Exercise 1,000 7.19 7,187
2007-05-15 Kolterman Orville G (Sr VP Clinical and Regulatory) Sale 6,700 42.29 283,335
2007-05-15 Kolterman Orville G (Sr VP Clinical and Regulatory) Option Exercise 6,700 2.03 13,607
2007-05-14 Baron Alain D (Sr VP Research) Sale 2,000 43.00 86,000
2007-05-14 Baron Alain D (Sr VP Research) Option Exercise 2,000 11.95 23,900
2007-05-14 Greene Howard E Jr (Director) Sale 3,846 42.90 165,011
2007-05-07 Bradbury Daniel (President & Chief Exec Officer) Sale 2,894 41.90 121,258
2007-05-02 Cook Joseph C Jr (Director) Sale 10,000 42.07 420,704
2007-05-01 Gergen Mark J (Sr VP, Corporate Development) Sale 500 41.25 20,625
2007-05-01 Gergen Mark J (Sr VP, Corporate Development) Option Exercise 500 16.80 8,400
2007-05-01 Rowland Lloyd A (VP, Gov/Compliance, Secretary) Sale 5,000 41.50 207,500
2007-05-01 Rowland Lloyd A (VP, Gov/Compliance, Secretary) Option Exercise 5,000 11.95 59,750
2007-05-01 Kolterman Orville G (Sr VP Clinical and Regulatory) Sale 5,000 41.12 205,583
2007-05-01 Kolterman Orville G (Sr VP Clinical and Regulatory) Option Exercise 5,000 .31 1,565
2007-04-30 Foletta Mark G (Senior VP, Finance & CFO) Sale 2,500 42.32 105,800
2007-04-30 Foletta Mark G (Senior VP, Finance & CFO) Option Exercise 2,500 13.25 33,125
2007-04-30 Greene Howard E Jr (Director) Sale 3,846 42.09 161,890
2007-04-27 Baron Alain D (Sr VP Research) Sale 2,000 43.00 86,000
2007-04-27 Baron Alain D (Sr VP Research) Option Exercise 2,000 11.95 23,900
2007-04-18 Cook Joseph C Jr (Director) Sale 10,000 41.94 419,375
2007-04-16 Kolterman Orville G (Sr VP Clinical and Regulatory) Sale 6,700 40.58 271,862
2007-04-16 Kolterman Orville G (Sr VP Clinical and Regulatory) Option Exercise 6,700 .55 3,664
2007-04-16 Baron Alain D (Sr VP Research) Sale 1,000 40.55 40,550
2007-04-16 Baron Alain D (Sr VP Research) Option Exercise 1,000 5.73 5,730
2007-04-16 Greene Howard E Jr (Director) Sale 3,846 41.46 159,445
2007-04-13 Kolterman Orville G (Sr VP Clinical and Regulatory) Sale 5,000 40.06 200,300
2007-04-13 Kolterman Orville G (Sr VP Clinical and Regulatory) Option Exercise 5,000 2.91 14,530
2007-04-13 Baron Alain D (Sr VP Research) Sale 1,000 40.06 40,060
2007-04-13 Baron Alain D (Sr VP Research) Option Exercise 1,000 5.73 5,730
2007-04-09 Bradbury Daniel (President & Chief Exec Officer) Sale 2,500 38.66 96,657
2007-04-04 Cook Joseph C Jr (Director) Sale 10,000 37.94 379,447
2007-04-02 Gergen Mark J (Sr VP, Corporate Development) Sale 500 37.47 18,735
2007-04-02 Gergen Mark J (Sr VP, Corporate Development) Option Exercise 500 16.80 8,400
2007-04-02 Rowland Lloyd A (VP Legal & General Counsel) Sale 2,000 36.95 73,901
2007-04-02 Rowland Lloyd A (VP Legal & General Counsel) Option Exercise 2,000 11.95 23,900
2007-04-02 Greene Howard E Jr (Director) Sale 3,846 37.12 142,778
2007-03-30 Foletta Mark G (Senior VP, Finance & CFO) Sale 2,500 37.61 94,025
2007-03-30 Foletta Mark G (Senior VP, Finance & CFO) Option Exercise 2,500 13.25 33,125
2007-03-22 Bradbury Daniel (President & Chief Operating) Option Exercise 39,269 10.49 411,905
2007-03-19 Cook Joseph C Jr (Director) Sale 10,000 37.71 377,149
2007-03-19 Greene Howard E Jr (Director) Sale 3,846 37.71 145,048
2007-03-15 Kolterman Orville G (Sr VP Clinical and Regulatory) Sale 6,700 38.20 255,930
2007-03-15 Kolterman Orville G (Sr VP Clinical and Regulatory) Option Exercise 6,700 .78 5,232
2007-03-07 Bradbury Daniel (President & Chief Operating) Sale 2,500 37.00 92,500
2007-03-05 Cook Joseph C Jr (Director) Sale 10,000 37.20 371,950
2007-03-05 Greene Howard E Jr (Director) Sale 3,846 37.20 143,071
2007-03-01 Gergen Mark J (Sr VP, Corporate Development) Sale 500 37.75 18,875
2007-03-01 Gergen Mark J (Sr VP, Corporate Development) Option Exercise 500 16.80 8,400
2007-03-01 Rowland Lloyd A (VP Legal & General Counsel) Sale 2,000 37.39 74,772
2007-03-01 Rowland Lloyd A (VP Legal & General Counsel) Option Exercise 2,000 11.95 23,900
2007-02-28 Foletta Mark G (Senior VP, Finance & CFO) Sale 2,500 38.82 97,050
2007-02-28 Foletta Mark G (Senior VP, Finance & CFO) Option Exercise 2,500 12.60 31,500
2007-02-20 Greene Howard E Jr (Director) Sale 3,846 40.49 155,710
2007-02-15 Kolterman Orville G (Sr VP Clinical and Regulatory) Sale 6,700 40.23 269,551
2007-02-15 Kolterman Orville G (Sr VP Clinical and Regulatory) Option Exercise 6,700 .78 5,232
2007-02-07 Bradbury Daniel (President & Chief Operating) Sale 3,500 40.52 141,820
2007-02-05 Greene Howard E Jr (Director) Sale 3,846 39.63 152,406
2007-02-01 Gergen Mark J (Sr VP, Corporate Development) Sale 500 38.75 19,375
2007-02-01 Gergen Mark J (Sr VP, Corporate Development) Option Exercise 500 16.80 8,400
2007-02-01 Rowland Lloyd A (VP Legal & General Counsel) Sale 2,000 38.92 77,840
2007-02-01 Rowland Lloyd A (VP Legal & General Counsel) Option Exercise 2,000 11.95 23,900
2007-02-01 Kolterman Orville G (Sr VP Clinical and Regulatory) Sale 5,000 38.69 193,426
2007-02-01 Kolterman Orville G (Sr VP Clinical and Regulatory) Option Exercise 5,000 14.38 71,875
2007-01-31 Foletta Mark G (Senior VP, Finance & CFO) Sale 2,500 39.00 97,500
2007-01-31 Foletta Mark G (Senior VP, Finance & CFO) Option Exercise 2,500 11.95 29,875
2007-01-22 Greene Howard E Jr (Director) Sale 3,846 39.55 152,103
2007-01-16 Kolterman Orville G (Sr VP Clinical and Regulatory) Sale 5,000 41.54 207,712
2007-01-16 Kolterman Orville G (Sr VP Clinical and Regulatory) Option Exercise 5,000 .78 3,905
2007-01-11 Kolterman Orville G (Sr VP Clinical and Regulatory) Sale 5,000 40.00 200,000
2007-01-11 Kolterman Orville G (Sr VP Clinical and Regulatory) Option Exercise 5,000 3.28 16,405
2007-01-09 Bradbury Daniel (President & Chief Operating) Sale 2,500 38.51 96,276
2007-01-08 Greene Howard E Jr (Director) Sale 3,846 38.16 146,761
2007-01-03 Gergen Mark J (Sr VP, Corporate Development) Sale 500 36.29 18,145
2007-01-03 Gergen Mark J (Sr VP, Corporate Development) Option Exercise 500 16.80 8,400

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of AMYLIN PHARMACEUTICALS INC (symbol AMLN, CIK number 881464) see the Securities and Exchange Commission (SEC) website.

© 2005-2008, insider-monitor.com. All rights reserved.